跳至主要内容
临床试验/EUCTR2005-005106-23-IT
EUCTR2005-005106-23-IT进行中(未招募)不适用

Allogeneic stem cell transplantation in children and adolescents with acute lymphoblastic leukemia - ALL SCT BFM International

ST. ANNA KINDERSPITA0 个研究点目标入组 405 人开始时间: 2009年8月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
405

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • patients with ALL (except for patients with B-ALL) who fulfil the following criteria: age at time of initial diagnosis or relapse diagnosis, respectively ≤18 years indication for allogeneic HSCT complete remission (CR) is achieved before SCT written consent of the parents (legal guardian) and, if indicated, the minor patient via Informed Consent Form no pregnancy no secondary malignancy no previous HSCT HSCT is performed in a study participating centre.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • gravidanza presunta o accertata diagnosi di seconda neoplasia maligna precedente TCSE

研究者

发起方
ST. ANNA KINDERSPITA

相似试验